United Scientific Group welcomes Fifth Edition of International Conference on Vaccines Research and Development (Vaccines R&D-2019) in Boston, MA during November 18-20, 2019.
This meeting will cover broad range of topics like new vaccine development, cancer vaccines and immunotherapy, infectious and non-infectious diseases, influenza vaccines, HIV vaccines, regulatory vaccines, therapeutic vaccination, bioprocessing & manufacturing and clinical trials.
Fifth Edition- International Conference on Vaccines Research and Development is a part of successful series of conference started from 2015 and held annually since then. The main objective of this conference is to bring together all the eminent persons of this field together to share their ideas and provides a critical review of present state of subject. It is designed in such a way that it provides an opportunity to meet up with people from both industry and academia and establish a scientific network between them.
Use of Bio-layer Interferometry in Vaccine Research and Development
Presenter: Hongshan Li Ph.D., Marketing Applications Manager
November 19, 2019
Bio-layer interferometry (BLI), label-free technology, has been broadly used in vaccine research and development with great success. The versatility of the Octet platform enables a multitude of approaches including epitope binning, whole virus capture, high throughput antibody screening, and much more. Key applications such as new vaccine development, cancer vaccines, influenza vaccines, bioprocessing, and clinical trials will be discussed.
The new Octet RED96e system is an enhancement to our industry-leading Octet RED96 instrument with additional capabilities to expand the number and types of samples that can be assayed, increasing access to data that can reduce the risk in bringing a drug candidate to market